Page last updated: 2024-08-23

sq-11725 and D-fructopyranose

sq-11725 has been researched along with D-fructopyranose in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leira, R; Pascual, J; Rivas, MT1
Bilbao, A; Foncea, N; Garcia-Monco, JC; Gomez-Beldarrain, M; Ruiz de Velasco, I1
Artal-Roy, J; García-Gómara, MJ; Gracia-Naya, M; Huerta-Villanueva, M; Latorre-Jiménez, AM; Mauri-Llerda, JA; Ríos-Gómez, C; Sánchez-Valiente, S; Santos-Lasaosa, S1
Artal-Roy, J; García-Gomara, MJ; Gracia-Naya, M; Latorre-Jiménez, AM; Mauri-Llerda, JA; Ríos-Gómez, C; Sánchez-Valiente, S; Santos-Lasaosa, S1

Trials

2 trial(s) available for sq-11725 and D-fructopyranose

ArticleYear
Testing the combination beta-blocker plus topiramate in refractory migraine.
    Acta neurologica Scandinavica, 2007, Volume: 115, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Female; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Neuroprotective Agents; Propranolol; Topiramate; Treatment Outcome

2007
Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients.
    Cephalalgia : an international journal of headache, 2007, Volume: 27, Issue:8

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anticonvulsants; Anxiety; Depression; Female; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Quality of Life; Surveys and Questionnaires; Topiramate

2007

Other Studies

2 other study(ies) available for sq-11725 and D-fructopyranose

ArticleYear
[Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients].
    Revista de neurologia, 2010, May-01, Volume: 50, Issue:9

    Topics: Adrenergic beta-Antagonists; Adult; Female; Fructose; Humans; Male; Migraine Disorders; Nadolol; Topiramate

2010
[Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine].
    Revista de neurologia, 2011, Aug-16, Volume: 53, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Anticonvulsants; Female; Flunarizine; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Neuroprotective Agents; Patient Dropouts; Patient Satisfaction; Prospective Studies; Risk Factors; Topiramate; Treatment Outcome; Young Adult

2011